SRPT vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

SRPT

29.5
AI Score
VS
RXRX Wins

RXRX

38.7
AI Score

Investment Advisor Scores

SRPT

30score
Recommendation
SELL

RXRX

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SRPT RXRX Winner
Forward P/E 6.1237 0 Tie
PEG Ratio 159.25 0 Tie
Revenue Growth -34.3% -60.1% SRPT
Earnings Growth 2663.8% 0.0% SRPT
Tradestie Score 29.5/100 38.7/100 RXRX
Profit Margin -6.9% 0.0% RXRX
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

SRPT 1M: +18.3% · 3M: +10.8% RXRX 1M: +16.3% · 3M: +12.5%

Current Technical Phase

SRPT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 59

RSI (14): 59.4 · Price: $18.79

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 58.7 · Price: $3.50

Fundamentals Snapshot

Metric SRPT RXRX
Market Cap
Forward P/E 7.5 -3.5
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% -0.6%
Gross Margin -0.2% -7.2%
Operating Margin 0.1% -17.6%
EPS -1.72 -1.00
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.